Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8304 |
Intermediate Similarity |
NPD750 |
Phase 2 |
0.8251 |
Intermediate Similarity |
NPD6999 |
Discontinued |
0.8251 |
Intermediate Similarity |
NPD7000 |
Clinical (unspecified phase) |
0.8132 |
Intermediate Similarity |
NPD7944 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD749 |
Clinical (unspecified phase) |
0.7989 |
Intermediate Similarity |
NPD7001 |
Phase 3 |
0.7957 |
Intermediate Similarity |
NPD7621 |
Clinical (unspecified phase) |
0.7943 |
Intermediate Similarity |
NPD482 |
Approved |
0.7941 |
Intermediate Similarity |
NPD6454 |
Clinical (unspecified phase) |
0.7937 |
Intermediate Similarity |
NPD5426 |
Phase 3 |
0.7933 |
Intermediate Similarity |
NPD2096 |
Phase 2 |
0.7933 |
Intermediate Similarity |
NPD2091 |
Phase 2 |
0.7906 |
Intermediate Similarity |
NPD7665 |
Phase 2 |
0.7906 |
Intermediate Similarity |
NPD7666 |
Phase 3 |
0.7895 |
Intermediate Similarity |
NPD6732 |
Clinical (unspecified phase) |
0.7877 |
Intermediate Similarity |
NPD2092 |
Phase 2 |
0.7877 |
Intermediate Similarity |
NPD2095 |
Phase 2 |
0.7877 |
Intermediate Similarity |
NPD2094 |
Phase 2 |
0.7836 |
Intermediate Similarity |
NPD2511 |
Approved |
0.7796 |
Intermediate Similarity |
NPD7818 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD7903 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD4852 |
Phase 2 |
0.7727 |
Intermediate Similarity |
NPD5934 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD201 |
Phase 2 |
0.7716 |
Intermediate Similarity |
NPD200 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD6375 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD8013 |
Clinical (unspecified phase) |
0.768 |
Intermediate Similarity |
NPD5728 |
Clinical (unspecified phase) |
0.767 |
Intermediate Similarity |
NPD4184 |
Clinical (unspecified phase) |
0.7668 |
Intermediate Similarity |
NPD8493 |
Clinical (unspecified phase) |
0.7667 |
Intermediate Similarity |
NPD6595 |
Phase 3 |
0.7656 |
Intermediate Similarity |
NPD6987 |
Phase 1 |
0.7647 |
Intermediate Similarity |
NPD7619 |
Phase 3 |
0.7647 |
Intermediate Similarity |
NPD7618 |
Phase 3 |
0.7624 |
Intermediate Similarity |
NPD4383 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD4703 |
Approved |
0.7619 |
Intermediate Similarity |
NPD4702 |
Approved |
0.7602 |
Intermediate Similarity |
NPD7470 |
Discontinued |
0.7581 |
Intermediate Similarity |
NPD6180 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD2896 |
Discontinued |
0.7552 |
Intermediate Similarity |
NPD5721 |
Clinical (unspecified phase) |
0.7545 |
Intermediate Similarity |
NPD751 |
Clinical (unspecified phase) |
0.754 |
Intermediate Similarity |
NPD5505 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD8000 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6610 |
Clinical (unspecified phase) |
0.7475 |
Intermediate Similarity |
NPD7594 |
Clinical (unspecified phase) |
0.7462 |
Intermediate Similarity |
NPD7998 |
Clinical (unspecified phase) |
0.7459 |
Intermediate Similarity |
NPD6203 |
Clinical (unspecified phase) |
0.7458 |
Intermediate Similarity |
NPD4174 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD1031 |
Discontinued |
0.7427 |
Intermediate Similarity |
NPD2172 |
Phase 1 |
0.7416 |
Intermediate Similarity |
NPD4640 |
Approved |
0.7416 |
Intermediate Similarity |
NPD4638 |
Approved |
0.7416 |
Intermediate Similarity |
NPD4639 |
Approved |
0.7409 |
Intermediate Similarity |
NPD5017 |
Discontinued |
0.7403 |
Intermediate Similarity |
NPD5471 |
Phase 3 |
0.74 |
Intermediate Similarity |
NPD7970 |
Approved |
0.74 |
Intermediate Similarity |
NPD7971 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD6661 |
Clinical (unspecified phase) |
0.7385 |
Intermediate Similarity |
NPD8272 |
Phase 2 |
0.7374 |
Intermediate Similarity |
NPD7809 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD4602 |
Approved |
0.7363 |
Intermediate Similarity |
NPD2144 |
Approved |
0.7354 |
Intermediate Similarity |
NPD6665 |
Discontinued |
0.7348 |
Intermediate Similarity |
NPD4736 |
Clinical (unspecified phase) |
0.7318 |
Intermediate Similarity |
NPD2844 |
Phase 3 |
0.7312 |
Intermediate Similarity |
NPD5555 |
Phase 1 |
0.731 |
Intermediate Similarity |
NPD6838 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD4075 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD1568 |
Clinical (unspecified phase) |
0.7302 |
Intermediate Similarity |
NPD2336 |
Approved |
0.7297 |
Intermediate Similarity |
NPD4345 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD5901 |
Discontinued |
0.7292 |
Intermediate Similarity |
NPD6664 |
Approved |
0.7287 |
Intermediate Similarity |
NPD6965 |
Clinical (unspecified phase) |
0.7286 |
Intermediate Similarity |
NPD7825 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD3654 |
Approved |
0.7278 |
Intermediate Similarity |
NPD1573 |
Approved |
0.7278 |
Intermediate Similarity |
NPD1575 |
Approved |
0.7278 |
Intermediate Similarity |
NPD3717 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD4426 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD4397 |
Phase 1 |
0.7253 |
Intermediate Similarity |
NPD5065 |
Approved |
0.7243 |
Intermediate Similarity |
NPD3038 |
Discontinued |
0.7239 |
Intermediate Similarity |
NPD3476 |
Approved |
0.7239 |
Intermediate Similarity |
NPD3475 |
Approved |
0.7238 |
Intermediate Similarity |
NPD5472 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD2390 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD4336 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD6344 |
Clinical (unspecified phase) |
0.7214 |
Intermediate Similarity |
NPD8093 |
Discontinued |
0.7213 |
Intermediate Similarity |
NPD5100 |
Phase 3 |
0.7211 |
Intermediate Similarity |
NPD6630 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD4547 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD3947 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD7712 |
Clinical (unspecified phase) |
0.7206 |
Intermediate Similarity |
NPD8405 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD786 |
Approved |
0.72 |
Intermediate Similarity |
NPD5257 |
Clinical (unspecified phase) |
0.7191 |
Intermediate Similarity |
NPD5400 |
Approved |
0.719 |
Intermediate Similarity |
NPD7824 |
Approved |
0.7189 |
Intermediate Similarity |
NPD5898 |
Approved |
0.7189 |
Intermediate Similarity |
NPD5897 |
Approved |
0.7189 |
Intermediate Similarity |
NPD5899 |
Approved |
0.7188 |
Intermediate Similarity |
NPD4427 |
Phase 2 |
0.7184 |
Intermediate Similarity |
NPD5965 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD6217 |
Discontinued |
0.7179 |
Intermediate Similarity |
NPD8248 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD8094 |
Discontinued |
0.7166 |
Intermediate Similarity |
NPD7564 |
Discontinued |
0.7166 |
Intermediate Similarity |
NPD6178 |
Phase 3 |
0.716 |
Intermediate Similarity |
NPD2119 |
Approved |
0.716 |
Intermediate Similarity |
NPD2118 |
Approved |
0.7158 |
Intermediate Similarity |
NPD5322 |
Clinical (unspecified phase) |
0.715 |
Intermediate Similarity |
NPD2307 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD4948 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD8431 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2012 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD198 |
Clinical (unspecified phase) |
0.7119 |
Intermediate Similarity |
NPD4326 |
Phase 2 |
0.711 |
Intermediate Similarity |
NPD1661 |
Suspended |
0.7108 |
Intermediate Similarity |
NPD3385 |
Approved |
0.7105 |
Intermediate Similarity |
NPD8110 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD7234 |
Approved |
0.7105 |
Intermediate Similarity |
NPD7233 |
Approved |
0.7102 |
Intermediate Similarity |
NPD2809 |
Approved |
0.71 |
Intermediate Similarity |
NPD2509 |
Approved |
0.71 |
Intermediate Similarity |
NPD2510 |
Approved |
0.7098 |
Intermediate Similarity |
NPD5975 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD6452 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD7730 |
Approved |
0.7095 |
Intermediate Similarity |
NPD7731 |
Approved |
0.7092 |
Intermediate Similarity |
NPD484 |
Approved |
0.709 |
Intermediate Similarity |
NPD5809 |
Phase 3 |
0.7089 |
Intermediate Similarity |
NPD7952 |
Approved |
0.7089 |
Intermediate Similarity |
NPD7950 |
Approved |
0.7089 |
Intermediate Similarity |
NPD7789 |
Approved |
0.7089 |
Intermediate Similarity |
NPD7953 |
Approved |
0.7089 |
Intermediate Similarity |
NPD7951 |
Approved |
0.7089 |
Intermediate Similarity |
NPD7790 |
Approved |
0.7089 |
Intermediate Similarity |
NPD7791 |
Approved |
0.7085 |
Intermediate Similarity |
NPD4862 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD7271 |
Approved |
0.7079 |
Intermediate Similarity |
NPD5255 |
Approved |
0.7077 |
Intermediate Similarity |
NPD6846 |
Clinical (unspecified phase) |
0.7074 |
Intermediate Similarity |
NPD3607 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD8406 |
Clinical (unspecified phase) |
0.7072 |
Intermediate Similarity |
NPD2642 |
Approved |
0.7072 |
Intermediate Similarity |
NPD2639 |
Approved |
0.7069 |
Intermediate Similarity |
NPD3100 |
Discontinued |
0.7068 |
Intermediate Similarity |
NPD4499 |
Approved |
0.7067 |
Intermediate Similarity |
NPD6995 |
Phase 1 |
0.7062 |
Intermediate Similarity |
NPD2580 |
Discontinued |
0.7062 |
Intermediate Similarity |
NPD4848 |
Phase 1 |
0.7056 |
Intermediate Similarity |
NPD3583 |
Phase 2 |
0.7056 |
Intermediate Similarity |
NPD1631 |
Approved |
0.7056 |
Intermediate Similarity |
NPD8129 |
Discovery |
0.7053 |
Intermediate Similarity |
NPD6141 |
Clinical (unspecified phase) |
0.7053 |
Intermediate Similarity |
NPD3486 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD7711 |
Discontinued |
0.7043 |
Intermediate Similarity |
NPD4076 |
Approved |
0.7043 |
Intermediate Similarity |
NPD4079 |
Approved |
0.7041 |
Intermediate Similarity |
NPD6137 |
Clinical (unspecified phase) |
0.7033 |
Intermediate Similarity |
NPD5069 |
Clinical (unspecified phase) |
0.7033 |
Intermediate Similarity |
NPD2185 |
Clinical (unspecified phase) |
0.7033 |
Intermediate Similarity |
NPD5862 |
Discovery |
0.7031 |
Intermediate Similarity |
NPD5592 |
Clinical (unspecified phase) |
0.7026 |
Intermediate Similarity |
NPD2880 |
Discontinued |
0.702 |
Intermediate Similarity |
NPD8073 |
Approved |
0.702 |
Intermediate Similarity |
NPD7187 |
Phase 2 |
0.7018 |
Intermediate Similarity |
NPD4805 |
Approved |
0.7018 |
Intermediate Similarity |
NPD1722 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4029 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4030 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4028 |
Approved |
0.7005 |
Intermediate Similarity |
NPD7168 |
Phase 3 |
0.7005 |
Intermediate Similarity |
NPD2305 |
Discontinued |
0.7005 |
Intermediate Similarity |
NPD8464 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7026 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD5820 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD3430 |
Approved |
0.6995 |
Remote Similarity |
NPD3431 |
Approved |
0.699 |
Remote Similarity |
NPD6710 |
Phase 3 |
0.6989 |
Remote Similarity |
NPD3506 |
Approved |
0.6989 |
Remote Similarity |
NPD3505 |
Approved |
0.6985 |
Remote Similarity |
NPD8072 |
Approved |
0.6981 |
Remote Similarity |
NPD7781 |
Approved |
0.6981 |
Remote Similarity |
NPD7780 |
Approved |
0.6979 |
Remote Similarity |
NPD3871 |
Clinical (unspecified phase) |
0.6979 |
Remote Similarity |
NPD6281 |
Approved |
0.6979 |
Remote Similarity |
NPD3870 |
Clinical (unspecified phase) |
0.6978 |
Remote Similarity |
NPD5611 |
Phase 2 |
0.6977 |
Remote Similarity |
NPD2006 |
Phase 2 |
0.6974 |
Remote Similarity |
NPD6449 |
Clinical (unspecified phase) |
0.6971 |
Remote Similarity |
NPD2430 |
Phase 2 |
0.6966 |
Remote Similarity |
NPD276 |
Clinical (unspecified phase) |
0.6963 |
Remote Similarity |
NPD3961 |
Discontinued |
0.6963 |
Remote Similarity |
NPD4988 |
Discontinued |
0.6963 |
Remote Similarity |
NPD3002 |
Clinical (unspecified phase) |
0.6954
|
Remote Similarity |
NPD6148 |
Clinical (unspecified phase) |